MENU
+Compare
RCEL
Stock ticker: NASDAQ
AS OF
Jul 25, 04:59 PM (EDT)
Price
$5.77
Change
-$0.21 (-3.51%)
Capitalization
399.48M

RCEL Avita Medical Forecast, Technical & Fundamental Analysis

Avita is a single product company... Show more

RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RCEL with price predictions
Jul 25, 2025

Aroon Indicator for RCEL shows an upward move is likely

RCEL's Aroon Indicator triggered a bullish signal on July 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 163 similar instances where the Aroon Indicator showed a similar pattern. In of the 163 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RCEL's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 21, 2025. You may want to consider a long position or call options on RCEL as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RCEL just turned positive on June 26, 2025. Looking at past instances where RCEL's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

RCEL moved above its 50-day moving average on July 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RCEL broke above its upper Bollinger Band on July 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RCEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.143) is normal, around the industry mean (24.533). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (7.849) is also within normal values, averaging (43.112).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RCEL is expected to report earnings to fall 52.72% to -25 cents per share on August 07

Avita Medical RCEL Stock Earnings Reports
Q2'25
Est.
$-0.25
Q1'25
Missed
by $0.21
Q4'24
Missed
by $0.10
Q3'24
Missed
by $0.19
Q2'24
Missed
by $0.12
The last earnings report on May 08 showed earnings per share of -52 cents, missing the estimate of -31 cents. With 210.04K shares outstanding, the current market capitalization sits at 399.48M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
28159 Avenue Stanford
Phone
+1 833 462-8482
Employees
207
Web
https://www.avitamedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNDJF3.600.02
+0.56%
Mandalay Resources Corp.
AGESF65.01N/A
N/A
ageas SA/NV
BUDFF70.52N/A
N/A
Anheuser Busch Inbev SA NV
FGROF2.75N/A
N/A
Firstgroup PLC
AINMF1.06N/A
-0.42%
NETRAMARK HLDGS INC.

RCEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with MRCHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then MRCHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
-4.47%
MRCHF - RCEL
38%
Loosely correlated
-3.20%
GMED - RCEL
36%
Loosely correlated
-1.39%
CERS - RCEL
34%
Loosely correlated
-6.21%
CTKB - RCEL
34%
Loosely correlated
-1.19%
MBOT - RCEL
32%
Poorly correlated
+8.30%
More